Neurocrine Biosciences Inc vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock trades at $235.5 (market cap $44.37B). The key difference: TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock is far larger — about 2.5× Neurocrine Biosciences Inc's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock nearer its low. Which is the better fit depends on your goals.
| NBIX | TTWO | |
|---|---|---|
Market Cap | $17.40B | $44.37B |
Sector | Health | Media |
52-Week High | $180.55 | $262.29 |
52-Week Low | $123.10 | $189.69 |
Enterprise Value | $16.49B | $45.34B |
Trailing returns across standard periods
Latest headlines on both assets
Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.
Read more on NBIX →Found in 1993, Take-Two consists of three wholly owned labels, Rockstar Games, 2K, and Zynga. The firm is one of the world's largest independent video game publishers on consoles, PCs, smartphones, and tablets. Take-Two's franchise portfolio is headlined by Grand Theft Auto (345 million units sold) and contains other well-known titles such as NBA 2K, Civilization, Borderlands, Bioshock, and Xcom. Zynga mobile titles include Farmville, Empires & Puzzles, and CSR Racing.
Read more on TTWO →